These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2462439)

  • 1. Phase II studies of bleomycin, ifosfamide and cis-platinum in advanced and recurrent cervical carcinoma.
    Buxton EJ; Meanwell CA; Mould JJ; Latief T; Chetiyawardana AD; Spooner D; Tobias JS; Sokal M; Alcock C; Hilton C
    Acta Oncol; 1988; 27(5):545-9. PubMed ID: 2462439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ifosfamide in cervical cancer.
    Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination bleomycin, ifosfamide, and cisplatin chemotherapy in cervical cancer.
    Buxton EJ; Meanwell CA; Hilton C; Mould JJ; Spooner D; Chetiyawardana A; Latief T; Paterson M; Redman CW; Luesley DM
    J Natl Cancer Inst; 1989 Mar; 81(5):359-61. PubMed ID: 2464699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II studies of ifosfamide alone and in combination in cancer of the cervix.
    Blackledge G; Buxton EJ; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S12-6. PubMed ID: 1693314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in recurrent and advanced cervical cancer.
    Kumar L; Bhargava VL
    Gynecol Oncol; 1991 Feb; 40(2):107-11. PubMed ID: 1707022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
    Singhal RM; Jindel R; Gupta AK
    Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single agent versus combination chemotherapy in recurrent cervical cancer.
    Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V
    J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look.
    Ramm K; Vergote IB; Kaern J; Tropé CG
    Gynecol Oncol; 1992 Aug; 46(2):203-7. PubMed ID: 1379961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma.
    Hempling RE; Eltabbakh GH; Piver MS; Recio FO; O'Neill CP
    Am J Clin Oncol; 1997 Jun; 20(3):315-8. PubMed ID: 9167762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
    Tay SK; Lai FM; Soh LT; Ho TH; Ang PT; Au E
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):263-6. PubMed ID: 1280100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.
    Herod J; Burton A; Buxton J; Tobias J; Luesley D; Jordan S; Dunn J; Poole CJ
    Ann Oncol; 2000 Sep; 11(9):1175-81. PubMed ID: 11061615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin, ifosfamide, and cisplatin (BIP) in patients with recurrent and advanced cervical cancer.
    Manetta A
    Gynecol Oncol; 1991 Jul; 42(1):104-5. PubMed ID: 1717353
    [No Abstract]   [Full Text] [Related]  

  • 14. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer.
    Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix.
    Choi CH; Kim TJ; Lee SJ; Lee JW; Kim BG; Lee JH; Bae DS
    Int J Gynecol Cancer; 2006; 16(3):1157-64. PubMed ID: 16803500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer.
    Hirabayashi K; Okada E
    Cancer; 1993 May; 71(9):2769-75. PubMed ID: 7682148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
    Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
    Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II study of ifosfamide and cisplatin chemotherapy for metastatic or relapsed carcinoma of the cervix.
    Coleman RE; Clarke JM; Slevin ML; Sweetenham J; Williams CJ; Blake P; Calman F; Wiltshaw E; Harper PG
    Cancer Chemother Pharmacol; 1990; 27(1):52-4. PubMed ID: 2245492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.